Grants and Contributions:
Title:
Refining NBx for industrial performance
Agreement Number:
1015922
Agreement Value:
$91,000.00
Agreement Date:
Mar 1, 2024 - Feb 28, 2026
Description:
Novel NBx Platform significantly improves productivity in plasmid DNA manufacturing, securing patents for engineered bacteria. Beyond enhancing productivity, this organism produces higher-quality material with fewer host-related impurities, benefiting various bio-based products, especially protein-based ones like growth factors.
The Human Growth Factor market, relying on E.coli, faces challenges of low yields and batch failures. Novel's bacteria demonstrates lower endotoxin production and up to 20X productivity in plasmid DNA manufacturing compared to E.coli. Building on this success, Novel aims to create a disruptive manufacturing platform for EGF and FGF growth factors, anticipating these advantages will transfer to other bioproducts.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Winnipeg, Manitoba, CA R2H 2A6
Reference Number:
172-2023-2024-Q4-1015922
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
793300708
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 1 days. The total amended value is -15,500 dollars.
Amendment Date
Sep 19, 2025
Recipient's Legal Name:
Novel Biotechnology Inc.
Federal Riding Name:
Saint Boniface--Saint Vital
Federal Riding Number:
46009
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254
Amendments: